Evidence map›Paper›PMID 32439725›Full record

ArticleHaematologica2021

A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.

Hiroki Mizumaki, Kazuyoshi Hosomichi, Kohei Hosokawa, Takeshi Yoroidaka, Tatsuya Imi, Yoshitaka Zaimoku, Takamasa Katagiri, Mai Anh Thi Nguyen, Dung Cao Tran, Mahmoud Ibrahim Yousef Elbadry and 10 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Hiroki MizumakiDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Kazuyoshi HosomichiGraduate School of Advanced Preventive Medical Sciences, Kanazawa University, Japan.
Kohei HosokawaDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Takeshi YoroidakaDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Tatsuya ImiDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Yoshitaka ZaimokuDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Takamasa KatagiriClinical Laboratory Sciences, Kanazawa University Graduate School, Kanazawa, Japan.
Mai Anh Thi NguyenDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Dung Cao TranDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Mahmoud Ibrahim Yousef ElbadryDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Kazuhisa ChonabayashiCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Yoshinori YoshidaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Hiroyuki TakamatsuDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Tatsuhiko OzawaDepartment of Immunology, University of Toyama, Toyama, Japan.
Fumihiro AzumaHLA Laboratory, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Kotoku, Japan.
Hiroyuki KishiDepartment of Immunology, University of Toyama, Toyama, Japan.
Yoichi FujiiDept. of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan.
Seishi OgawaDept. of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan.
Atsushi TajimaGraduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
Shinji NakaoDepartment of Hematology, Kanazawa University, Kanazawa, Japan.
Kanazawa University · JPKyoto University · JPUniversity of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukocytes that lack HLA allelic expression are frequently detected in patients with acquired aplastic anemia (AA) who respond to immunosuppressive therapy (IST), although the exact mechanisms underlying the HLA loss and HLA allele repertoire likely to acquire loss-of-function mutations are unknown. We identified a common nonsense mutation at position 19 (c.19C>T, p.R7X) in exon 1 (Exon1mut) of different HLA-A and -B alleles in HLA-lacking granulocytes from AA patients. A droplet digital PCR (ddPCR) assay capable of detecting as few as 0.07% Exon1mut HLA alleles in total DNA revealed the mutation was present in 29% (101/353) of AA patients, with a median allele frequency of 0.42% (range, 0.071% to 21.3%). Exon1mut occurred in only 12 different HLA-A (n=4) and HLA-B (n=8) alleles, including B*40:02 (n=31) and A*02:06 (n=15), which correspond to 4 HLA supertypes (A02, A03, B07, and B44). The percentages of patients who possessed at least one of these 12 HLA alleles were significantly higher in the 353 AA patients (92%, P.

Indexed as

Anemia, AplasticCodon, NonsenseAllelesExonsHLA-A AntigensHLA-B AntigensHumansCodon, NonsenseHLA-A AntigensHLA-B Antigens

Identifiers

PMID32439725
PMCPMC8168509
OpenAlexW3026237322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.